Affordable Access

deepdyve-link
Publisher Website

Glimepiride strongly enhances the glucose-lowering effect in triple oral antidiabetes therapy with sitagliptin and metformin for Japanese patients with type 2 diabetes mellitus.

Authors
  • Arai, Keiko
  • Maeda, Hajime
  • Sirabe, Sin-ichiro
  • Yamamoto, Ritsuko
  • Yamauchi, Mikio
  • Hirao, Tetsuyuki
  • Hirao, Setsuko
  • Hirao, Koichi
Type
Published Article
Journal
Diabetes Technology & Therapeutics
Publisher
Mary Ann Liebert
Publication Date
Apr 01, 2013
Volume
15
Issue
4
Pages
335–341
Identifiers
DOI: 10.1089/dia.2012.0287
PMID: 23480592
Source
Medline
License
Unknown

Abstract

Glimepiride is important for good glycemic control in triple OAD therapy with sitaglitpin and metformin. This regimen may be useful for those patients who do not achieve satisfactory glycemic control with dual combination therapy.

Report this publication

Statistics

Seen <100 times